327 related articles for article (PubMed ID: 25016084)
1. In vitro activity of MCB3681 against Clostridium difficile strains.
Rashid MU; Dalhoff A; Weintraub A; Nord CE
Anaerobe; 2014 Aug; 28():216-9. PubMed ID: 25016084
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden.
Rashid MU; Lozano HM; Weintraub A; Nord CE
Anaerobe; 2013 Apr; 20():32-5. PubMed ID: 23454525
[TBL] [Abstract][Full Text] [Related]
3. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
5.
Freeman J; Pilling S; Vernon J; Wilcox MH
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993853
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
Poilane I; Fantinato C; Cruaud P; Collignon A
Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain.
Reigadas E; Alcalá L; Marín M; Pelaéz T; Martin A; Iglesias C; Bouza E
J Antimicrob Chemother; 2015 Aug; 70(8):2311-5. PubMed ID: 25876881
[TBL] [Abstract][Full Text] [Related]
10. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
[TBL] [Abstract][Full Text] [Related]
11. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
Kim J; Kang JO; Pai H; Choi TY
Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
[TBL] [Abstract][Full Text] [Related]
12. Toxin profiles, PCR ribotypes and resistance patterns of Clostridium difficile: a multicentre study in China, 2012-2013.
Gao Q; Wu S; Huang H; Ni Y; Chen Y; Hu Y; Yu Y
Int J Antimicrob Agents; 2016 Dec; 48(6):736-739. PubMed ID: 27793509
[TBL] [Abstract][Full Text] [Related]
13. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.
Gerding DN; Hecht DW; Louie T; Nord CE; Talbot GH; Cornely OA; Buitrago M; Best E; Sambol S; Osmolski JR; Kracker H; Locher HH; Charef P; Wilcox M
J Antimicrob Chemother; 2016 Jan; 71(1):213-9. PubMed ID: 26433782
[TBL] [Abstract][Full Text] [Related]
15. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile recurrences in Stockholm.
Sandell S; Rashid MU; Jorup-Rönström C; Ellström K; Nord CE; Weintraub A
Anaerobe; 2016 Apr; 38():97-102. PubMed ID: 26802875
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
[TBL] [Abstract][Full Text] [Related]
20. Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012.
Beran V; Kuijper EJ; Harmanus C; Sanders IM; van Dorp SM; Knetsch CW; Janeckova J; Seidelova A; Barekova L; Tvrdik J; Chmelar D; Ciznar I
Folia Microbiol (Praha); 2017 Sep; 62(5):445-451. PubMed ID: 28332133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
